Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prestige Consumer Healthcare (PBH) Cost of Revenue: 2010-2025

Historic Cost of Revenue for Prestige Consumer Healthcare (PBH) over the last 16 years, with Mar 2025 value amounting to $503.3 million.

  • Prestige Consumer Healthcare's Cost of Revenue fell 3.06% to $122.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $487.5 million, marking a year-over-year decrease of 2.01%. This contributed to the annual value of $503.3 million for FY2025, which is 0.48% up from last year.
  • Prestige Consumer Healthcare's Cost of Revenue amounted to $503.3 million in FY2025, which was up 0.48% from $500.9 million recorded in FY2024.
  • Prestige Consumer Healthcare's 5-year Cost of Revenue high stood at $503.3 million for FY2025, and its period low was $395.9 million during FY2021.
  • In the last 3 years, Prestige Consumer Healthcare's Cost of Revenue had a median value of $502.4 million in 2023 and averaged $502.2 million.
  • As far as peak fluctuations go, Prestige Consumer Healthcare's Cost of Revenue dropped by 3.63% in 2021, and later climbed by 17.75% in 2022.
  • Prestige Consumer Healthcare's Cost of Revenue (Yearly) stood at $395.9 million in 2021, then rose by 17.75% to $466.2 million in 2022, then increased by 7.78% to $502.4 million in 2023, then declined by 0.30% to $500.9 million in 2024, then grew by 0.48% to $503.3 million in 2025.